Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Deadly Liver Mob: opening the door – improving sexual health pathways for Aboriginal people in Western Sydney

Karen Biggs A B , Jennifer Walsh A D and Catriona Ooi A C
+ Author Affiliations
- Author Affiliations

A Western Sydney Sexual Health Centre, Western Sydney Local Health District, 162 Marsden Street, Parramatta, NSW 2150, Australia.

B Sydney Nursing School, University of Sydney, 88 Mallett Street, Camperdown, NSW 2050, Australia.

C Sydney Medical School – Westmead, University of Sydney, NSW 2006, Australia.

D Corresponding author. Email: Jennifer.walsh@health.nsw.gov.au

Sexual Health 13(5) 457-464 https://doi.org/10.1071/SH15176
Submitted: 4 September 2015  Accepted: 4 May 2016   Published: 4 July 2016

Abstract

Background: The Deadly Liver Mob project (DLM) is an incentive-based, peer-driven health promotion intervention for Aboriginal people, focusing on hepatitis C and offering education and screening for sexually transmissible infections (STI) and blood-borne viruses (BBV). This study aims to assess the DLM effect on attendance and STI/BBV screening, describe BBV risk factors and report infection rates among Aboriginal people attending Western Sydney Sexual Health Centre (WSSHC). Methods: A retrospective review of Aboriginal clients during the first year of the DLM project was compared with Aboriginal clients who attended during the 5.3 years before implementation of the project. Data on attendance, screening rates, demographics, lifestyle information and STI/BBV results were extracted. Results: There was a 10-fold increase in the number of Aboriginal people attending, via the DLM project (P < 0.01). The DLM group were more likely to be male (47 vs 28%), ≥ 35 years (46 vs 27%), report injecting drug use (IDU) (43 vs 26%), a history of incarceration (48 vs 24%) or unsafe tattooing (36 vs 16%) and have comprehensive STI/BBV testing (85 vs 54%); (P < 0.01 for all). There were 79 positive results and 30 commenced hepatitis B vaccination in the DLM period, compared with 15 and 19, in the non-DLM period. Conclusions: The DLM project effectively increased sexual healthcare attendance and screening for Aboriginal people in Western Sydney. The DLM has fostered ongoing care and facilitated service engagement for individuals at high risk of contracting STIs and BBVs.

Additional keywords: blood-borne viruses, incentives, incentive-based, Indigenous health, Needle Syringe Program (NSP), peer-referral, sexually transmissible infections.


References

[1]  Australian Indigenous HealthInfoNet. Overview of Australian Indigenous health status, 2014. Mt Lawley, WA: Australian Indigenous HealthInfoNet; 2015. Available online at: http://www.healthinfonet.ecu.edu.au/health-facts/overviews [verified 2 July 2015].

[2]  The Kirby Institute. Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: annual surveillance report 2015. Sydney: The Kirby Institute, UNSW; 2015. Available online at: http://www.kirby.unsw.edu.au [verified 6 January 2016].

[3]  Mooney-Somers J, Erick W, Scott R, Akee A, Kaldor J, Maher L. Enhancing Aboriginal and Torres Strait Islander young people’s resilience to blood-borne and sexually transmitted infections: findings from a community-based participatory research project. Health Promot J Austr 2009; 20 195–201.
| 19951239PubMed |

[4]  Ward J, Bryant J, Worth H, Hull P, Solar S, Bailey S. Use of health services for sexually transmitted and blood-borne viral infections by young Aboriginal people in New South Wales. Aust J Primary Health 2013; 19 81–6.
Use of health services for sexually transmitted and blood-borne viral infections by young Aboriginal people in New South Wales.Crossref | GoogleScholarGoogle Scholar |

[5]  Commonwealth of Australia. Fourth National Aboriginal and Torres Strait Islander Blood-borne Virus and Sexually Transmissible Infections Strategy 2014–2017. Canberra: Department of Health; 2014.

[6]  NSW Ministry of Health (NSW MoH). NSW HIV Strategy 2012–2015 a new era. Sydney: NSW MoH; 2012. Available online at: http://www.health.nsw.gov.au/publications/Publications/nsw-hiv-strategy-2012-15.pdf [Verified March 2015].

[7]  New South Wales (NSW) Government, Ministry of Health (MoH). NSW Sexually Transmissible Infections Strategy 2016–2020. Sydney: NSW MoH; 2016.

[8]  NSW Ministry of Health. NSW Hepatitis B Strategy 2014–2020. Sydney: NSW MoH; 2014 Available online at: http://www.health.nsw.gov.au/hepatitis/Pages/HepatitisBStrategy.aspx [verified 11 February 2016].

[9]  NSW Ministry of Health. NSW Hepatitis C Strategy 2014–2020. Sydney: NSW MoH; 2014. Available online at: http://www.health.nsw.gov.au/hepatitis/Pages/hepatitiscstrategy.aspx [verified 11 February 2016].

[10]  NSW Government Land and Property Information. Atlas of New South Wales: Indigenous population. Sydney: NSW Government; 2015. Available online at: http://www.atlas.nsw.gov.au/public/nsw/home/topic/article/indigenous-population.html [verified 22 June 2015].

[11]  Currie B, Iversen J, Maher L. New South Wales needle and syringe program enhanced data collection 2014: Western Sydney Local Health District Report. Sydney: The Kirby Institute, UNSW; 2014.

[12]  Broadhead R, Heckathorn D, Weakliem D, Anthony D, Madray H, Mills R, Hughes J. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep 1998; 113 42–57.
| 9722809PubMed |

[13]  Hughes J. Paying injection drug users to educate and recruit their peers: why participant-driven interventions are an ethical public health model. Qual Manag Health Care 1999; 7 4–12.
Paying injection drug users to educate and recruit their peers: why participant-driven interventions are an ethical public health model.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1MvgtlGmtQ%3D%3D&md5=4c300d64c357151f97692633c1e4b925CAS | 10557398PubMed |

[14]  Australian Institute of Health and Welfare. National best practice guidelines for collecting Indigenous status in health data sets. Cat. no. IHW 29. Canberra: AIHW; 2010.

[15]  Currie MJ, Schmidt M, Davis BK, Baynes AM, O’Keefe EJ, Bavinton TP, McNiven M, Martin SJ, Bowden FJ. ‘Show me the money’: financial incentives increase chlamydia screening rates among tertiary students: a pilot study. Sex Health 2010; 7 60–5.
‘Show me the money’: financial incentives increase chlamydia screening rates among tertiary students: a pilot study.Crossref | GoogleScholarGoogle Scholar | 20152098PubMed |

[16]  Higgins ST, Washio Y, Heil SH, Solomon LJ, Gaalema DE, Higgins TM, Bernstein IM. Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med 2012; 55 S33–40.
Financial incentives for smoking cessation among pregnant and newly postpartum women.Crossref | GoogleScholarGoogle Scholar | 22227223PubMed |

[17]  Higgins ST, Silverman K, Sigmon SC, Naito NA. Incentives and health: an introduction. Prev Med 2012; 55 S2–6.
Incentives and health: an introduction.Crossref | GoogleScholarGoogle Scholar | 22554884PubMed |

[18]  Topp L, Day CA, Wand H, Deacon RM, van Beek I, Haber PS, Shanahan M, Rodgers C, Maher L. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Hepatitis Acceptability and Vaccine Incentives Trial (HAVIT) Study Group. Prev Med 2013; 57 297–303.
A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Hepatitis Acceptability and Vaccine Incentives Trial (HAVIT) Study Group.Crossref | GoogleScholarGoogle Scholar | 23639625PubMed |

[19]  Zenner D, Molinar D, Nichols T, Riha J, Macintosh M, Nardone A. Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening. BMC Public Health 2012; 12 261
Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening.Crossref | GoogleScholarGoogle Scholar | 22471791PubMed |

[20]  Australian Injecting & Illicit Drug Users League (AIVL). A framework for peer education by drug-user organisations. Canberra: AIVL Hepatitis C Peer Education & Prevention Program; 2006.

[21]  Australian Government, Department of Health and Ageing. National Male Health Policy: Building on the strengths of Australian males. Canberra: Commonwealth of Australia; 2010. Available online at http://www.health.gov.au/internet/main/publishing.nsf/Content/7935AC78159969D4CA257BF0001C6B07/$File/MainDocument.pdf [verified 22 June 2015].

[22]  Iversen J, Maher L. Australian NSP Survey: Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program attendees 20 Year National Data Report 1995–2014. Sydney: The Kirby Institute for Infection and Immunity in Society, UNSW; 2015.

[23]  McIver R, Dyda A, Knight V, Guy R, McNulty A. Hepatitis B screening and vaccination: how does a sexual health service measure up? Sex Health 2015; 12 458–9.
Hepatitis B screening and vaccination: how does a sexual health service measure up?Crossref | GoogleScholarGoogle Scholar |